Søgeresultater - Diane Reidy‐Lagunes

Refine Results
  1. 1
    Targeted Therapies in Neuroendocrine Tumors (NET): Clinical Trial Challenges and Lessons Learned

    Targeted Therapies in Neuroendocrine Tumors (NET): Clinical Trial Challenges and Lessons Learned af James C. Yao, Diane Reidy Lagunes, Matthew H. Kulke

    Udgivet 2013
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  2. 2
    A Retrospective Review of 126 High-Grade Neuroendocrine Carcinomas of the Colon and Rectum

    A Retrospective Review of 126 High-Grade Neuroendocrine Carcinomas of the Colon and Rectum af James D. Smith, Diane Reidy‐Lagunes, Karyn A. Goodman, Jinru Shia, Garrett M. Nash

    Udgivet 2014
    Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  3. 3
    Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology

    Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology af Nitya Raj, Emily Valentino, Marinela Capanu, Laura H. Tang, Olca Baştürk, Brian R. Untch, Peter J. Allen, David S. Klimstra, Diane Reidy‐Lagunes

    Udgivet 2016
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  4. 4
    A phase 2 study of the insulin‐like growth factor‐1 receptor inhibitor MK‐0646 in patients with metastatic, well‐differentiated neuroendocrine tumors

    A phase 2 study of the insulin‐like growth factor‐1 receptor inhibitor MK‐0646 in patients with metastatic, well‐differentiated neuroendocrine tumors af Diane Reidy‐Lagunes, Efsevia Vakiani, Michal Segal, Ellen Hollywood, Laura H. Tang, David B. Solit, M. Catherine Pietanza, Marinela Capanu, Leonard B. Saltz

    Udgivet 2012
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  5. 5
    Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas

    Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas af Laura H. Tang, Brian R. Untch, Diane Reidy‐Lagunes, Eileen M. O’Reilly, Deepti Dhall, Lily Jih, Olca Baştürk, Peter J. Allen, David S. Klimstra

    Udgivet 2015
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  6. 6
    Faster FOLFOX: Oxaliplatin Can Be Safely Infused at a Rate of 1 mg/m<sup>2</sup>/min

    Faster FOLFOX: Oxaliplatin Can Be Safely Infused at a Rate of 1 mg/m<sup>2</sup>/min af Andrea Cercek, Vivian Park, Rona Yaeger, Diane Reidy‐Lagunes, Nancy E. Kemeny, Zsofia K. Stadler, Neil H. Segal, Anna M. Varghese, Leonard B. Saltz

    Udgivet 2016
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  7. 7
    Biodistribution and radiation dose estimates for 68Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors

    Biodistribution and radiation dose estimates for 68Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors af Simone Krebs, Neeta Pandit‐Taskar, Diane Reidy‐Lagunes, Bradley J. Beattie, Serge K. Lyashchenko, Jason S. Lewis, Lisa Bodei, Wolfgang Weber, Joseph A. O’Donoghue

    Udgivet 2018
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  8. 8
    Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies

    Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies af Andrea Cercek, Taryn Boucher, Jill S. Gluskin, Ariel Aguiló, Joanne F. Chou, Louise C. Connell, Marinela Capanu, Diane Reidy‐Lagunes, Michael I. D’Angelica, Nancy E. Kemeny

    Udgivet 2016
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  9. 9
    Limited role of Chromogranin A as clinical biomarker for pancreatic neuroendocrine tumors

    Limited role of Chromogranin A as clinical biomarker for pancreatic neuroendocrine tumors af Alessandra Pulvirenti, Deepthi Rao, Caitlin A. McIntyre, Mithat Gönen, Laura H. Tang, David S. Klimstra, Martin Fleisher, Lakshmi V. Ramanathan, Diane Reidy‐Lagunes, Peter J. Allen

    Udgivet 2018
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  10. 10
    False-Positive Elevations of Carcinoembryonic Antigen in Patients With a History of Resected Colorectal Cancer

    False-Positive Elevations of Carcinoembryonic Antigen in Patients With a History of Resected Colorectal Cancer af Anya M. Litvak, Andrea Cercek, Neil H. Segal, Diane Reidy‐Lagunes, Zsofia K. Stadler, Rona Yaeger, Nancy E. Kemeny, Martin R. Weiser, Melissa S. Pessin, Leonard B. Saltz

    Udgivet 2014
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  11. 11
    Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors

    Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors af Timothy J. Hobday, Rui Qin, Diane Reidy‐Lagunes, Malcolm J. Moore, Jonathan Strosberg, Andreas Kaubisch, Manisha H. Shah, Hedy L. Kindler, Heinz‐Josef Lenz, Helen Chen, Charles Erlichman

    Udgivet 2014
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  12. 12
    Ganetespib, a Novel Hsp90 Inhibitor in Patients With KRAS Mutated and Wild Type, Refractory Metastatic Colorectal Cancer

    Ganetespib, a Novel Hsp90 Inhibitor in Patients With KRAS Mutated and Wild Type, Refractory Metastatic Colorectal Cancer af Andrea Cercek, Jinru Shia, Marc J. Gollub, Joanne F. Chou, Marinela Capanu, Pamela Joan Raasch, Diane Reidy‐Lagunes, David A. Proia, Efsevia Vakiani, David B. Solit, Leonard B. Saltz

    Udgivet 2014
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  13. 13
    Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist 177Lu-Satoreotide Tetraxetan

    Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist 177Lu-Satoreotide Tetraxetan af Diane Reidy‐Lagunes, Neeta Pandit‐Taskar, Joseph A. O’Donoghue, Simone Krebs, Kevin D. Staton, Serge K. Lyashchenko, Jason S. Lewis, Nitya Raj, Mithat Gönen, Christian Lohrmann, Lisa Bodei, Wolfgang Weber

    Udgivet 2019
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  14. 14
    Complete Responses to Mitotane in Metastatic Adrenocortical Carcinoma—A New Look at an Old Drug

    Complete Responses to Mitotane in Metastatic Adrenocortical Carcinoma—A New Look at an Old Drug af Diane Reidy‐Lagunes, Betty Y Lung, Brian R. Untch, Nitya Raj, Anastasia E. Hrabovsky, Ciara M. Kelly, Scott R. Gerst, Seth S. Katz, Lewis J. Kampel, Joanne F. Chou, Anu Gopalan, Leonard B. Saltz

    Udgivet 2017
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  15. 15
    Biodistribution and Dosimetry of <sup>18</sup>F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies

    Biodistribution and Dosimetry of <sup>18</sup>F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies af Neeta Pandit‐Taskar, Pat Zanzonico, Kevin D. Staton, Jorge A. Carrasquillo, Diane Reidy‐Lagunes, Serge K. Lyashchenko, Eva Burnazi, Hanwen Zhang, Jason S. Lewis, Ronald G. Blasberg, Steven M. Larson, Wolfgang Weber, Shakeel Modak

    Udgivet 2017
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  16. 16
    Randomized, Phase II Study of the Insulin-Like Growth Factor-1 Receptor Inhibitor IMC-A12, With or Without Cetuximab, in Patients With Cetuximab- or Panitumumab-Refractory Metastatic Colorectal Cancer

    Randomized, Phase II Study of the Insulin-Like Growth Factor-1 Receptor Inhibitor IMC-A12, With or Without Cetuximab, in Patients With Cetuximab- or Panitumumab-Refractory Metastat... af Diane Reidy‐Lagunes, Efsevia Vakiani, Marwan Fakih, Muhammad Wasif Saif, J. Randolph Hecht, Noah Goodman-Davis, Ellen Hollywood, Jinru Shia, Jonathan Schwartz, Kumari Chandrawansa, Aruna Dontabhaktuni, Hagop Youssoufian, David B. Solit, Leonard B. Saltz

    Udgivet 2010
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  17. 17
    Neoadjuvant Chemotherapy Without Routine Use of Radiation Therapy for Patients With Locally Advanced Rectal Cancer: A Pilot Trial

    Neoadjuvant Chemotherapy Without Routine Use of Radiation Therapy for Patients With Locally Advanced Rectal Cancer: A Pilot Trial af Deborah Schrag, Martin R. Weiser, Karyn A. Goodman, Mithat Gönen, Ellen Hollywood, Andrea Cercek, Diane Reidy‐Lagunes, Marc J. Gollub, Jinru Shia, José G. Guillem, Larissa K. Temple, Philip B. Paty, Leonard B. Saltz

    Udgivet 2014
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  18. 18
    Pilot Trial of Combined BRAF and EGFR Inhibition in <i>BRAF</i>-Mutant Metastatic Colorectal Cancer Patients

    Pilot Trial of Combined BRAF and EGFR Inhibition in <i>BRAF</i>-Mutant Metastatic Colorectal Cancer Patients af Rona Yaeger, Andrea Cercek, Eileen M. O’Reilly, Diane Reidy‐Lagunes, Nancy E. Kemeny, Tamar Wolinsky, Marinela Capanu, Marc J. Gollub, Neal Rosen, Michael F. Berger, Mario E. Lacouture, Efsevia Vakiani, Leonard B. Saltz

    Udgivet 2015
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  19. 19
    NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy

    NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy af Thomas A. Hope, Lisa Bodei, Jennifer A. Chan, Ghassan El‐Haddad, Nicholas Fidelman, Pamela L. Kunz, Josh Mailman, Yusuf Menda, David C. Metz, Erik Mittra, Daniel A. Pryma, Diane Reidy‐Lagunes, Simron Singh, Jonathan Strosberg

    Udgivet 2020
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  20. 20
    Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline Actionability

    Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline Actionability af Nitya Raj, Ronak Shah, Zsofia K. Stadler, Semanti Mukherjee, Joanne F. Chou, Brian R. Untch, Janet Li, Virginia Kelly, Muyinat Osoba, Leonard B. Saltz, Diana Mandelker, Marc Ladanyi, Michael F. Berger, David S. Klimstra, Diane Reidy‐Lagunes

    Udgivet 2018
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:

Søgeredskaber: